Sarepta FDA Shipment Halt - Search News

Order byBest matchMost fresh

News

Sarepta Therapeutics, FDA and gene

· 8d · on MSN

Sarepta Refused FDA’s Request to Halt Elevidys Shipments

The Food and Drug Administration plans to ask Sarepta Therapeutics Inc. to pause shipments of its Elevidys treatment after three deaths were linked to the company’s gene therapies, according to a person familiar with the matter.

Continue reading

BioPharma Dive · 5d

FDA asks Sarepta to stop shipping Duchenne gene therapy

Fierce Pharma · 5d

Sarepta stands behind Elevidys after FDA requests gene therapy be pulled from market

3d

Elevidys Halt Sparks Analyst Downgrades—Sarepta Races To Revise Label

Analysts downgraded Sarepta as FDA pause on Elevidys raises regulatory uncertainty, leading to significant stock pressure and ...

Cambridge biopharmaceutical company lays off nearly 500 workers

This Massachusetts-based biopharmaceutical company announced hundreds of layoffs last week. Here's what the CEO said about it ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results